A share price of Akoya Biosciences Inc [AKYA] is currently trading at $1.30, up 22.64%. Until recently, the best way to gauge how the stock has performed was to look at its short-term value. The AKYA shares have gain 37.46% over the last week, with a monthly amount glided 11.11%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Akoya Biosciences Inc [NASDAQ: AKYA] stock has seen the most recent analyst activity on November 15, 2024, when Craig Hallum downgraded its rating to a Hold and also revised its price target to $5 from $7. Previously, Morgan Stanley downgraded its rating to Equal-Weight on August 06, 2024. On August 06, 2024, downgrade downgraded it’s rating to Neutral. BTIG Research downgraded its rating to a Neutral. Craig Hallum initiated its recommendation with a Buy and recommended $7.50 as its price target on June 21, 2024.
Akoya Biosciences Inc experienced fluctuations in its stock price throughout the past year between $0.93 and $3.42. Currently, Wall Street analysts expect the stock to reach $2.4 within the next 12 months. Akoya Biosciences Inc [NASDAQ: AKYA] shares were valued at $1.30 at the most recent close of the market. An investor can expect a potential return of 84.62% based on the average AKYA price forecast.
Analyzing the AKYA fundamentals
Trailing Twelve Months sales for Akoya Biosciences Inc [NASDAQ:AKYA] were 79.96M which represents -9.32% decline. Gross Profit Margin for this corporation currently stands at 0.62% with Operating Profit Margin at -0.48%, Pretax Profit Margin comes in at -0.59%, and Net Profit Margin reading is -0.59%. To continue investigating profitability, this company’s Return on Assets is posted at -0.42, Equity is -5.06 and Total Capital is -8.44. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at -14.22.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance.
Ratios To Look Out For
To put it in perspective, the Current Ratio for Akoya Biosciences Inc [NASDAQ:AKYA] is 0.61. As well, the Quick Ratio is 0.40, while the Cash Ratio is 0.19. Considering the valuation of this stock, the price to sales ratio is 0.81.
Transactions by insiders
Recent insider trading involved McKelligon Brian, President and CEO, that happened on Jun 11 ’24 when 7500.0 shares were sold. President and CEO, McKelligon Brian completed a deal on Jun 06 ’24 to sell 7500.0 shares.
